Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology.
D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005602:France; D018073:Haemophilus Vaccines; D006801:Humans; D007223:Infant; D007267:Injections; D008297:Male; D008875:Middle Aged; D022242:Pneumococcal Vaccines; D012141:Respiratory Tract Infections / Q000473:pathology / Q000517:prevention & control*; D012270:Ribosomes / Q000276:immunology*; D022541:Streptococcal Vaccines; D014937:Work
D000336:Aerosols; D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; D022242:Pneumococcal Vaccines; D022541:Streptococcal Vaccines; C024220:D 53